Roche Canada and the pan-Canadian Pharmaceutical Alliance successfully complete negotiations for Vabysmo (faricimab injection) for the treatment of neovascular (wet) age-related macular degeneration and diabetic macular oedema

29 May 2023 - Roche Canada today announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for ...

Read more →

Australians battling with prostate cancer to benefit from new PBS listing

25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...

Read more →

FORUS Therapeutics and the Pan-Canadian Pharmaceutical Alliance complete negotiations for Xpovio (selinexor)

24 May 2023 - The pCPA agreement will support the public listings and reimbursement of Xpovio. ...

Read more →

New life changing treatment for dwarfism added to PBS

24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...

Read more →

Biden-Harris Administration announces proposal to advance prescription drug transparency in Medicaid

23 May 2023 - New HHS proposal would shed light on cost of prescription drugs and save states and federal ...

Read more →

SMA patients protest inconsistent reimbursement standards for Spinraza

19 May 2023 - Spinal muscular atrophy patients taking Spinraza (nusinersen sodium) are protesting against the Health Insurance Review and ...

Read more →

Astellas seeks to expand reimbursement for prostate cancer drug Xtandi

16 May 2023 - Astellas Pharma has set about to rectify the reimbursement track for Xtandi (enzalutamide), its prostate cancer ...

Read more →

RACGP welcomes asthma puffer decision saving Aussie families time and money

15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...

Read more →

Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

12 May 2023 - The study authors said the estimated costs to the program for seniors are conservative and spending ...

Read more →

PBAC backs ongoing access to low-dose asthma puffer for Aussie kids

12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...

Read more →

Ovarian cancer: Bay of Plenty mother spends more than $130,000 on treatments

12 May 2023 - Four cancer treatments in three years: $132,775. ...

Read more →

Reforming opioid dependence treatment access

10 May 2023 - In the 2023-24 Budget, the Australian Government committed $377.3 million over 4 years from 2023–24 (and $98.4 ...

Read more →

Patients lose access to free medicines amid spat between drugmakers, health plans

2 May 2023 - Pharmaceutical companies have cut financial assistance to thwart health plan tactics. ...

Read more →

Access to cancer medicines in the UK

1 May 2023 - On 31 January 2020, the UK formally ended it's 47 year membership of the EU. As a ...

Read more →

Gene therapies are still hampered by substantial delays between approval and launch

3 May 2023 - Gene therapies hold promise for treating a wide range of diseases. Innovative companies such as bluebird bio ...

Read more →